Skip to main content
Ipca Laboratories Ltd. logo

Ipca Laboratories Ltd. — Investor Relations & Filings

Ticker · IPCALAB ISIN · INE571A01038 LEI · 33580069PZ8ZQVCDBC38 BSE.NS Manufacturing
Open in API
Filings indexed 742 across all filing types
Latest filing 2026-06-09 Regulatory Filings
Country IN India
Listing BSE.NS IPCALAB

About Ipca Laboratories Ltd.

https://www.ipca.com

Ipca Laboratories Ltd. is a vertically integrated entity focused on the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs) and finished dosage formulations. The company serves a global market, distributing products to over 120 countries. Its therapeutic portfolio covers rheumatology, antimalarials, cardiology, gastroenterology, pain management, and diabetology. Notably, it is a leading global producer of antimalarial agents such as Chloroquine and Hydroxychloroquine. Operations are supported by multiple manufacturing sites that adhere to international regulatory standards, alongside dedicated research and development centers. The company’s strategic emphasis on backward integration allows for optimized production processes and the delivery of high-quality medicinal solutions across diverse healthcare sectors.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2026-06-09 English
Eclsoed copy of newspapers
Regulatory Filings Classification · 85% confidence The document is a short compliance announcement filed under Regulation 30 of SEBI LODR, enclosing a newspaper notice to shareholders regarding the transfer of equity shares to the IEPF Authority. It does not itself contain financial statements, voting results, or capital changes, nor is it an actual report. This is a general regulatory filing/notice to stock exchanges. Therefore it falls under the “Regulatory Filings” category (RNS).
2026-06-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is introduced under Regulation 30 for a Conference Call held on June 1, 2026 to discuss Q4 FY26 earnings. It includes the full transcript with moderator and Q&A session, matching the definition of a Call Transcript.
2026-06-04 English
Transcript of Conference Call held on 1st June 2026
Call Transcript Classification · 95% confidence The document is a SEBI Regulation 30 filing enclosing the full transcript of the company’s Q4 FY26 earnings conference call, including moderator commentary, management opening remarks, financial metrics discussion, and a Q&A session. This is clearly a call transcript rather than an earnings press release or other report. Therefore, it should be classified as a Call Transcript (CT).
2026-06-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 73% confidence The document is a brief stock exchange filing under SEBI Listing Regulations (Regulation 30) providing a link to the audio of a Q4 FY26 earnings conference call. It does not contain actual financial data or the call transcript itself; it is simply a regulatory disclosure. This does not qualify as an earnings release (ER), call transcript (CT), or any substantive report. Therefore it falls into the catch-all Regulatory Filings category (RNS).
2026-06-01 English
Audio Link of the Conference Call held on 01.06.2026
Report Publication Announcement Classification · 87% confidence The document is a brief SEBI Reg. 30 disclosure providing an audio link (and pointing to transcripts) for the Company’s Q4 FY26 conference call. It does not contain the earnings release or the call transcript itself, but simply announces where the call audio/transcript can be accessed. Under the “menu vs. meal” rule, this is an announcement of a report (the conference call transcript/audio), not the report itself. This matches the Report Publication Announcement (RPA) category.
2026-06-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.